Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Philippe Menu currently holds 164,671 shares of SOPHiA GENETICS SA (SOPH), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Philippe Menu has been a net neutral trader of SOPH stock. They have purchased $0 and sold $0 worth of shares.
Philippe Menu's most recent insider trade was on Apr 2, 2026, when they sold 164,671 shares at $0.00 per share.
Philippe Menu serves as Chief Medical Officer at SOPHiA GENETICS SA (SOPH). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Philippe Menu holds the position of Chief Medical Officer at SOPHiA GENETICS SA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Philippe Menu has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Philippe Menu was on Apr 2, 2026, when they purchased $0 worth of SOPH shares. This transaction involved 164,671 shares at N/A per share.
Philippe Menu currently owns 164,671 shares of SOPHiA GENETICS SA (SOPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Philippe Menu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Philippe Menu has 2 Form 4 filings on record as an insider at SOPHiA GENETICS SA.
Set alerts for Philippe Menu and 40,000+ other insiders.